Associate Consultant, Singapore General Hospital

Pathology

Yan Khor, MB CHB

Khor works in the field of Pathology. Khor is a published physician. She has 18 papers published. The most current publication "PKA knockdown enhances cell killing in response to radiation and androgen deprivation."

Publications

Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer.
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.
Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10.
Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10.
MDM2 as a predictor of prostate carcinoma outcome: an analysis of Radiation Therapy Oncology Group Protocol 8610.
Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells.
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Th...
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.
Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10.
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.
Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivo.
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202.
PKA knockdown enhances cell killing in response to radiation and androgen deprivation.
Survivin is a potential mediator of prostate cancer metastasis.
Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression.
The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02.
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.

Doctors Specialties

Cytopathology
Pathology

Accepted Insurances

Education

Cleveland Clinic Foundation
Case Western Reserve University - University Hospitals
Drexel University - Hahnemann University Hospital
Royal College of Surgeons Ireland

Hospital

Cleveland Clinic

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Charles V. Biscotti, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Maryann Fitzmaurice, MD This Doctor is OpenDoctor Recommended.
	Dr. Bin Yang, MD This Doctor is OpenDoctor Recommended.
	Dr. Vincent M. Monnier, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jordan P. Reynolds, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark J. Melaragno, MD This Doctor is OpenDoctor Recommended.
	Dr. Eva M. Bashover, MD This Doctor is OpenDoctor Recommended.
	Dr. Niki Stamos, MD This Doctor is OpenDoctor Recommended.